127 related articles for article (PubMed ID: 7641306)
1. Resistance of highly branched (1-->3)-beta-D-glucans to formolysis.
Ohno N; Terui T; Chiba N; Kurachi K; Adachi Y; Yadomae T
Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1057-60. PubMed ID: 7641306
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of (1-->3)-beta-D-glucan in mice.
Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T
Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
[TBL] [Abstract][Full Text] [Related]
4. Purification of an antitumor-active, branched (1----3)-beta-D-glucan from Volvariella volvacea, and elucidation of its fine structure.
Kishida E; Sone Y; Misaki A
Carbohydr Res; 1989 Oct; 193():227-39. PubMed ID: 2611783
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacological characterization of a highly branched fungal (1-->3)-beta-D-glucan, OL-2, isolated from Omphalia lapidescens.
Ohno N; Saito K; Nemoto J; Kaneko S; Adachi Y; Nishijima M; Miyazaki T; Yadomae T
Biol Pharm Bull; 1993 Apr; 16(4):414-9. PubMed ID: 8358393
[TBL] [Abstract][Full Text] [Related]
6. Preparation and antigen specificity of an anti-(1-->3)-beta-D-glucan antibody.
Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1994 Nov; 17(11):1508-12. PubMed ID: 7703974
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6.
Demleitner S; Kraus J; Franz G
Carbohydr Res; 1992 Mar; 226(2):239-46. PubMed ID: 1617687
[TBL] [Abstract][Full Text] [Related]
8. Preparation and biological activities of sulfated derivatives of (1----3)-beta-D-glucans.
Suzuki T; Ohno N; Adachi Y; Cirelli AF; Covian JA; Yadomae T
J Pharmacobiodyn; 1991 May; 14(5):256-66. PubMed ID: 1770430
[TBL] [Abstract][Full Text] [Related]
9. Refinement of the structures of cell-wall glucans of Schizosaccharomyces pombe by chemical modification and NMR spectroscopy.
Sugawara T; Takahashi S; Osumi M; Ohno N
Carbohydr Res; 2004 Sep; 339(13):2255-65. PubMed ID: 15337454
[TBL] [Abstract][Full Text] [Related]
10. Structure of pestalotan, a highly branched (1----3)-beta-D-glucan elaborated by Pestalotia sp. 815, and the enhancement of its antitumor activity by polyol modification of the side chains.
Misaki A; Kawaguchi K; Miyaji H; Nagae H; Hokkoku S; Kakuta M; Sasaki T
Carbohydr Res; 1984 Jul; 129():209-27. PubMed ID: 6547877
[TBL] [Abstract][Full Text] [Related]
11. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
Suda M; Ohno N; Hashimoto T; Koizumi K; Adachi Y; Yadomae T
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):93-100. PubMed ID: 8880133
[TBL] [Abstract][Full Text] [Related]
12. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
Kurachi K; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2527-31. PubMed ID: 2285987
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumour activity of sulfoalkyl derivatives of curdlan and lichenan.
Demleitner S; Kraus J; Franz G
Carbohydr Res; 1992 Mar; 226(2):247-52. PubMed ID: 1617688
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the antitumor effect and tissue distribution of highly branched (1-->3)-beta-D-glucan, SSG, by carrageenan.
Suda M; Ohno N; Adachi Y; Yadomae T
Biol Pharm Bull; 1995 May; 18(5):772-5. PubMed ID: 7492998
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characteristics and antitumor activities of a highly branched fungal (1----3)-beta-D-glucan, OL-2, isolated from Omphalia lapidescens.
Ohno N; Miura T; Saito K; Nishijima M; Miyazaki T; Yadomae T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2215-8. PubMed ID: 1423785
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
Suda M; Ohno N; Adachi Y; Yadomae T
J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of Limulus amoebocyte lysate towards (1----3)-beta-D-glucans.
Ohno N; Emori Y; Yadomae T; Saito K; Masuda A; Oikawa S
Carbohydr Res; 1990 Oct; 207(2):311-8. PubMed ID: 2076521
[TBL] [Abstract][Full Text] [Related]
18. Antitumor beta glucan from the cultured fruit body of Agaricus blazei.
Ohno N; Furukawa M; Miura NN; Adachi Y; Motoi M; Yadomae T
Biol Pharm Bull; 2001 Jul; 24(7):820-8. PubMed ID: 11456124
[TBL] [Abstract][Full Text] [Related]
19. Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa.
Adachi Y; Ohno N; Ohsawa M; Sato K; Oikawa S; Yadomae T
Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1838-43. PubMed ID: 2805163
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cytokine mRNAs induced by the administration of a highly branched (1-->3)-beta-D-glucan, OL-2.
Nemoto J; Ohno N; Saito K; Adachi Y; Yadomae T
Biol Pharm Bull; 1994 Jul; 17(7):948-54. PubMed ID: 8000384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
